Defining the role of corticotropin releasing factor binding protein in alcohol consumption

Translational Psychiatry

Volumn 6, Issue 11, 2016, Pages

  Haass Koffler, C L ^a,b   Henry, A T ^c   Melkus, G ^d   Simms, J A ^e   Naemmuddin, M ^e   Nielsen, C K ^e   Lasek, A W ^f   Magill, M ^b   Schwandt, M L ^a   Momenan, R ^a   Hodgkinson, C A ^a   Bartlett, S E ^g   Swift, R M ^b   Bonci, A ^h   Leggio, L ^a,b  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d UNIVERSITY OF OTTAWA   (Canada)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^g QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^h JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CARRIER PROTEIN; CORTICOTROPIN RELEASING FACTOR-BINDING PROTEIN;

ALCOHOLISM; AMYGDALA; ANIMAL; BLOOD FLOW; CELL MEMBRANE; COMPARATIVE STUDY; DOWN REGULATION; DRINKING BEHAVIOR; GENE EXPRESSION; GENETICS; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INBRED MOUSE STRAIN; KNOCKOUT MOUSE; MALE; METABOLISM; MOUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; SPECIES DIFFERENCE; YOUNG ADULT;

ALCOHOL DRINKING; ALCOHOLISM; AMYGDALA; ANIMALS; CALCIUM; CARRIER PROTEINS; CELL MEMBRANE; DOWN-REGULATION; GENE EXPRESSION; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; PITUITARY-ADRENAL SYSTEM; REGIONAL BLOOD FLOW; SPECIES SPECIFICITY; YOUNG ADULT;

EID: 85019273353     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/TP.2016.208     Document Type: Article

References (45)

1. Sarnyai Z, Shaham Y, Heinrichs SC. The role of corticotropin-releasing factor in drug addiction. Pharmacol Rev 2001; 53: 209–243.
2. Shaham Y, Erb S, Stewart J. Stress-induced relapse to heroin and cocaine seeking in rats: a review. Brain Res Rev 2000; 33: 13–33.
3. Haass-Koffler CL, Bartlett SE. Stress and addiction: contribution of the corticotropin releasing factor (CRF) system in neuroplasticity. Front Mol Neurosci 2012; 5: 91.
4. Woods RJ, Kemp CF, David J, Sumner IG, Lowry PJ. Cleavage of recombinant human corticotropin-releasing factor (CRF)-binding protein produces a 27-kilodalton fragment capable of binding CRF. J Clin Endocr Metab 1999; 84: 2788–2794.
5. Potter E, Behan DP, Linton EA, Lowry PJ, Sawchenko PE, Vale WW. The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF. Proc Natl Acad Sci USA 1992; 89: 4192–4196.
6. Slater PG, Noches V, Gysling K. Corticotropin-releasing factor type-2 receptor and corticotropin-releasing factor-binding protein coexist in rat ventral tegmental area nerve terminals originated in the lateral hypothalamic area. Eur J Neurosci 2016; 43: 220–229.
7. Albrechet-Souza L, Hwa LS, Han X, Zhang EY, DeBold JF, Miczek KA. Corticotropin releasing factor binding protein and CRF2 receptors in the ventral tegmental area: modulation of ethanol binge drinking in C57BL/6 J mice. Alcohol Clin Exp Res 2015; 39: 1609–1618.
8. Wang B, You ZB, Rice KC, Wise RA. Stress-induced relapse to cocaine seeking: roles for the CRF(2) receptor and CRF-binding protein in the ventral tegmental area of the rat. Psychopharmacology 2007; 193: 283–294.
9. Ungless MA, Singh V, Crowder TL, Yaka R, Ron D, Bonci A. Corticotropin-releasing factor requires CRF binding protein to potentiate NMDA receptors via CRF receptor 2 in dopamine neurons. Neuron 2003; 39: 401–407.
10. Rubinson DA, Dillon CP, Kwiatkowski AV, Sievers C, Yang L, Kopinja J et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 2003; 33: 401–406.
11. Lasek AW, Janak PH, He L, Whistler JL, Heberlein U. Downregulation of mu opioid receptor by RNA interference in the ventral tegmental area reduces ethanol consumption in mice. Genes Brain Behav 2007; 6: 728–735.
12. Rhodes JS, Best K, Belknap JK, Finn DA, Crabbe JC. Evaluation of a simple model of ethanol drinking to intoxication in C57BL/6 J mice. Physiol Behav 2005; 84: 53–63.
13. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559–575.
14. Lovenberg TW, Liaw CW, Grigoriadis DE, Clevenger W, Chalmers DT, De Souza EB et al. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci USA 1995; 92: 836–840.
15. Liaw CW, Grigoriadis DE, Lovenberg TW, De Souza EB, Maki RA. Localization of ligand-binding domains of human corticotropin-releasing factor receptor: a chimeric receptor approach. Mol Endocrinol 1997; 11: 980–985.
16. Zhao Y, Valdez GR, Fekete EM, Rivier JE, Vale WW, Rice KC et al. Subtype-selective corticotropin-releasing factor receptor agonists exert contrasting, but not oppo-site, effects on anxiety-related behavior in rats. J Pharmacol Exp Ther 2007; 323: 846–854.
17. Fekete EM, Zorrilla EP. Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs. Front Neuroendocrinol 2007; 28: 1–27.
18. Magalhaes AC, Holmes KD, Dale LB, Comps-Agrar L, Lee D, Yadav PN et al. CRF receptor 1 regulates anxiety behavior via sensitization of 5-HT2 receptor signal-ing. Nat Neurosci 2010; 13: 622–629.
19. Muller MB, Zimmermann S, Sillaber I, Hagemeyer TP, Deussing JM, Timpl P et al. Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress. Nat Neurosci 2003; 6: 1100–1107.
20. Karolyi IJ, Burrows HL, Ramesh TM, Nakajima M, Lesh JS, Seong E et al. Altered anxiety and weight gain in corticotropin-releasing hormone-binding protein-deficient mice. Proc Natl Acad Sci USA 1999; 96: 11595–11600.
21. Haas DA, George SR. Estradiol or ovariectomy decreases CRF synthesis in hypo-thalamus. Brain Res Bull 1989; 23: 215–218.
22. Beckerman MA, Van Kempen TA, Justice NJ, Milner TA, Glass MJ. Corticotropin-releasing factor in the mouse central nucleus of the amygdala: ultrastructural distribution in NMDA-NR1 receptor subunit expressing neurons as well as projection neurons to the bed nucleus of the stria terminalis. Exp Neurol 2013; 239: 120–132.
23. Behan DP, Khongsaly O, Owens MJ, Chung HD, Nemeroff CB, De Souza EB. Corticotropin-releasing factor (CRF), CRF-binding protein (CRF-BP), and CRF/ CRF-BP complex in Alzheimer's disease and control postmortem human brain. J Neurochem 1997; 68: 2053–2060.
24. Roberto M, Cruz MT, Gilpin NW, Sabino V, Schweitzer P, Bajo M et al. Corticotropin releasing factor-induced amygdala gamma-aminobutyric acid release plays a key role in alcohol dependence. Biol Psychiatry 2010; 67: 831–839.
25. Simms JA, Haass-Koffler CL, Bito-Onon J, Li R, Bartlett SE. Mifepristone in the central nucleus of the amygdala reduces yohimbine stress-induced reinstatement of ethanol-seeking. Neuropsychopharmacology 2012; 37: 906–918.
26. Ray LA. Stress-induced and cue-induced craving for alcohol in heavy drinkers: preliminary evidence of genetic moderation by the OPRM1 and CRH-BP genes. Alcohol Clin Exp Res 2011; 35: 166–174.
27. Enoch MA, Shen PH, Ducci F, Yuan Q, Liu J, White KV et al. Common genetic origins for EEG, alcoholism and anxiety: the role of CRH-BP. PLoS One 2008; 3: e3620.
28. Roy A, Hodgkinson CA, Deluca V, Goldman D, Enoch MA. Two HPA axis genes, CRHBP and FKBP5, interact with childhood trauma to increase the risk for suicidal behavior. J Psychiatr Res 2012; 46: 72–79.
29. Slater PG, Cerda CA, Pereira LA, Andres ME, Gysling K. CRF binding protein facilitates the presence of CRF type 2alpha receptor on the cell surface. Proc Natl Acad Sci USA 2016; 113: 4075–4080.
30. Behan DP, De Souza EB, Lowry PJ, Potter E, Sawchenko P, Vale WW. Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides. Front Neuroendocrinol 1995; 16: 362–382.
31. Janssen D, Kozicz T. Is it really a matter of simple dualism? Corticotropin-releasing factor receptors in body and mental health. Front Endocrinol (Lausanne) 2013; 4: 28.
32. Kaur S, Li J, Stenzel-Poore MP, Ryabinin AE. Corticotropin-releasing factor acting on corticotropin-releasing factor receptor type 1 is critical for binge alcohol drinking in mice. Alcohol Clin Exp Res 2012; 36: 369–376.
33. Heilig M, Koob GF. A key role for corticotropin-releasing factor in alcohol dependence. Trends Neurosci 2007; 30: 399–406.
34. Ketchesin KD, Seasholtz AF. Novel roles for CRF-binding protein and CRF receptor 2 in binge drinking. Alcohol Clin Exp Res 2015; 39: 2296–2298.
35. Ryabinin AE, Tsoory MM, Kozicz T, Thiele TE, Neufeld-Cohen A, Chen A et al. Urocortins: CRF's siblings and their potential role in anxiety, depression and alcohol drinking behavior. Alcohol 2012; 46: 349–357.
36. Sparta DR, Hopf FW, Gibb SL, Cho SL, Stuber GD, Messing RO et al. Binge ethanol-drinking potentiates corticotropin releasing factor R1 receptor activity in the ventral tegmental area. Alcohol Clin Exp Res 2013; 37: 1680–1687.
37. Lowery EG, Spanos M, Navarro M, Lyons AM, Hodge CW, Thiele TE. CRF-1 antagonist and CRF-2 agonist decrease binge-like ethanol drinking in C57BL/6 J mice independent of the HPA axis. Neuropsychopharmacology 2010; 35: 1241–1252.
38. Pleil KE, Rinker JA, Lowery-Gionta EG, Mazzone CM, McCall NM, Kendra AM et al. NPY signaling inhibits extended amygdala CRF neurons to suppress binge alcohol drinking. Nat Neurosci 2015; 18: 545–552.
39. Westphal NJ, Seasholtz AF. CRH-BP: the regulation and function of a phylogen-etically conserved binding protein. Front Biosci 2006; 11: 1878–1891.
40. Gammie SC, Seasholtz AF, Stevenson SA. Deletion of corticotropin-releasing factor binding protein selectively impairs maternal, but not intermale aggression. Neuro-science 2008; 157: 502–512.
41. Seasholtz AF, Burrows HL, Karolyi IJ, Camper SA. Mouse models of altered CRH-binding protein expression. Peptides 2001; 22: 743–751.
42. Seasholtz AF, Valverde RA, Denver RJ. Corticotropin-releasing hormone-binding protein: biochemistry and function from fishes to mammals. J Endocrinol 2002; 175: 89–97.
43. Sparta DR, Sparrow AM, Lowery EG, Fee JR, Knapp DJ, Thiele TE. Blockade of the corticotropin releasing factor type 1 receptor attenuates elevated ethanol drinking associated with drinking in the dark procedures. Alcohol Clin Exp Res 2008; 32: 259–265.
44. Lowery-Gionta EG, Navarro M, Li C, Pleil KE, Rinker JA, Cox BR et al. Corticotropin releasing factor signaling in the central amygdala is recruited during binge-like ethanol consumption in C57BL/6J mice. J Neurosci 2012; 32: 3405–3413.
45. Ketchesin KD, Stinnett GS, Seasholtz AF. Binge drinking decreases corticotropin-releasing factor-binding protein expression in the medial prefrontal cortex of mice. Alcohol Clin Exp Res 2016; 40: 1641–1650.